Becton, Dickinson and Co. | BDX - Operating Expenses

Stock Price
152.13
Daily Change
-2.72 -1.76%
Monthly
-3.88%
Yearly
-25.82%
Q2 Forecast
155.05

Becton, Dickinson and Co. reported $4.59B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Agilent USD 1.44B 27M Dec/2025
Align Technology USD 822.85M 11.8M Dec/2025
AngioDynamics USD 81.95M 1.68M Sep/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 423M 1.06B Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Globus Medical USD 645.11M 241.46M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
Intuitive Surgical USD 1.91B 89.8M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Masimo USD 328.6M 181.6M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Solventum Corp USD 1.89B 3.09B Dec/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025